Myxoid adrenal cortical adenoma

Pathol Int. 2001 Nov;51(11):887-91. doi: 10.1046/j.1440-1827.2001.01287.x.

Abstract

Myxoid adrenal cortical adenoma is a rare tumor and, to our knowledge, only 16 cases have been reported. We present the case of a 56-year-old Japanese man who was admitted to hospital because of a right adrenal mass that was discovered during a routine physical examination. The resected mass was well circumscribed and contained canary yellow multinodular regions that were surrounded by a brown gelatinous region. Histologically, the multinodular regions resembled a conventional adrenal cortical adenoma, being composed of solid aggregates of large clear or eosinophilic cells. In the gelatinous region, anastomosing small eosinophilic or vesicular cells were visible within a myxoid stroma that contained large amounts of acidic mucopolysaccharides. Light-microscopic findings were consistent with a diagnosis of adenoma. Immunohistochemical staining revealed that a small number of tumor cells were positive for vimentin, and the MIB-1 labeling index was less than 1%. Flow cytometry demonstrated that cells were diploid. At the ultrastructural level, many fat droplets were found in the large clear cells in the multinodular regions. Small eosinophilic cells in the myxoid region contained many mitochondria but few fat droplets. There were no findings suggestive of malignancy. Although the adrenal cortex might have the potential to produce connective tissue-type mucin as a consequence of its mesodermal origin, the mechanism of production of acidic mucopolysaccharides in a myxoid adrenal cortical tumor remains to be clarified.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Neoplasms / chemistry
  • Adrenal Cortex Neoplasms / pathology*
  • Adrenal Cortex Neoplasms / surgery
  • Adrenocortical Adenoma / chemistry
  • Adrenocortical Adenoma / pathology*
  • Adrenocortical Adenoma / surgery
  • Antigens, Nuclear
  • Biomarkers, Tumor / analysis
  • Cytoplasm / ultrastructure
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen
  • Male
  • Middle Aged
  • Myxoma / chemistry
  • Myxoma / pathology*
  • Myxoma / surgery
  • Nuclear Proteins / analysis
  • Treatment Outcome
  • Vimentin / analysis

Substances

  • Antigens, Nuclear
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Nuclear Proteins
  • Vimentin